摘要
背景:研究显示舞蹈等身体活动对改善痴呆症患者认知功能储备有积极影响。 目的:本研究的目的是探讨痴呆症患者的舞蹈疗效,并列举舞蹈疗法对于这些人的主要益处和局限性。 方法:本研究采用的方法包括在公认的数据库PubMed,Web of Science,Springer和Scopus中对跳舞疗法和痴呆的可用英文文献进行文献综述的方法,以及比较和评估方法的发现。 结果:这个迷你评论的结果证实,舞蹈治疗对痴呆患者的认知,身体,情绪和社交表现有积极的效果。 结论:该领域应进行更多的随机对照临床试验,以及其他非药物治疗,以全面促进痴呆的预防和治疗。
关键词: 痴呆,跳舞,疗效,发现,好处,局限性,评论。
Current Alzheimer Research
Title:Dancing as an Intervention Tool for People with Dementia: A Mini-Review Dancing and Dementia
Volume: 14 Issue: 12
关键词: 痴呆,跳舞,疗效,发现,好处,局限性,评论。
摘要: Background: Research studies show a positive impact of physical activities such as dancing on the improvement of cognitive reserves of people with dementia.
Objective: The purpose of this study is to explore dancing efficacy on people with dementia and list the key benefits and limitations of dancing therapy for these people.
Methods: The methods used in this study include a method of literature review of available Englishwritten sources with respect to the dancing therapy and dementia in the acknowledged databases Pub- Med, Web of Science, Springer, and Scopus, and a method of comparison and evaluation of their findings.
Results: The findings of this mini review confirm positive efficacy of dancing therapy on cognitive, physical, emotional and social performance of people with dementia.
Conclusion: More randomized controlled clinical trials should be conducted in this field, as well as other non-pharmacological therapies should be employed in order to holistically contribute to the prevention and treatment of dementia.
Export Options
About this article
Cite this article as:
Dancing as an Intervention Tool for People with Dementia: A Mini-Review Dancing and Dementia, Current Alzheimer Research 2017; 14 (12) . https://dx.doi.org/10.2174/1567205014666170713161422
DOI https://dx.doi.org/10.2174/1567205014666170713161422 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
Anti-Cancer Agents in Medicinal Chemistry Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound
CNS & Neurological Disorders - Drug Targets MicroRNA Dysregulation in Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets New Therapeutic Strategy for Parkinson’s and Alzheimer’s Disease
Current Medicinal Chemistry Targeting Beta-Amyloid Pathogenesis Through Acetylcholinesterase Inhibitors
Current Pharmaceutical Design Event-related Potentials Improve the Efficiency of Cerebrospinal Fluid Biomarkers for Differential Diagnosis of Alzheimer’s Disease
Current Alzheimer Research Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response
Current Pharmaceutical Design Plasma Acetylcholinesterase Activity Correlates with Intracerebral β-Amyloid Load
Current Alzheimer Research Novel Target Sites for Drug Screening: A Special Reference to Cancer, Rheumatoid Arthritis and Parkinson’s Disease
Current Signal Transduction Therapy Editorial [Hot topic: Fixing Alzheimer Disease Trials by Improving Process and Methods (Lon S. Schneider)]
Current Alzheimer Research Regulation of Endothelial Nitric Oxide Synthase in Pathophysiological Conditions
Cardiovascular & Hematological Disorders-Drug Targets Incidence and Prevalence of Hypothyroidism in Patients Affected by Chronic Heart Failure: Role of Amiodarone
Endocrine, Metabolic & Immune Disorders - Drug Targets Preface [Hot Topic: Amyloidogenic Proteins and Peptides Involved in Human Neurodegenerative Diseases (Guest Editor: Brian m. Austen)]
Protein & Peptide Letters Safety of Dipeptidyl Peptidase 4 Inhibitors for Treatment of Type 2 Diabetes
Current Drug Safety Pharmacogenomics in Psychiatry: Implications for Practice
Recent Patents on Biotechnology η-Secretase: Reduction of Amyloid Precursor Protein η-Site Cleavage in Alzheimers Disease
Current Alzheimer Research A Role for Calcineurin in Alzheimers Disease
Current Neuropharmacology Research and Development of Nuclear Molecular Imaging in Taiwan
Current Medical Imaging Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk
Current Pharmaceutical Design Alzheimer’s Disease is Associated with Increased Risk of Osteoporosis: The Chongqing Aging Study
Current Alzheimer Research